Trials / Completed
CompletedNCT06614374
Fish Oil for Cognitive Function, Sleep Quality, and Bone Density
Effects of n-3 Fatty Acids on Cognitive Function, Sleep Quality, and Bone Mineral Density in Diabetic Patients: an Ancillary Study of the Precision Nutritional Management for Diabetes (PNMD) Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 415 (actual)
- Sponsor
- Jingjing Jiao · Academic / Other
- Sex
- All
- Age
- 40 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The Precision Nutritional Management for Diabetes trial (PNMD; NCT03708887) is a randomized clinical trial in 415 diabetic patients investigating whether taking daily dietary supplements of omega-3 fatty acids (1.5 or 3 grams) improves glucose and lipid homeostasis in Chinese diabetic patients. This ancillary study is being conducted among PNMD participants and will examine whether fish oil supplements affect A) cognitive function, B) sleep quality, and C) bone mineral density. Cognitive function, sleep quality, and bone mineral density will be evaluated at baseline and post-intervention. The Mini-Mental State Exams (MMSE) will be conducted to evaluate the cognitive function of participants. The Pittsburgh Sleep Quality Index (PSQI) will be calculated through questionnaires to evaluate sleep quality. The Dual-emission X-ray Absorptiometry (DXA) will be assessed to measure the bone density.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Low-dose fish oil capsules | Patients in the low-dose group will receive four fish-oil and refined olive oil mixed capsules containing 1.5 g of marine n-3 PUFAs per day. |
| DIETARY_SUPPLEMENT | High-dose fish oil capsules | Patients in the high-dose group will receive four fish oil capsules containing 3 g of marine n-3 PUFAs (72% EPA and 28% DHA) per day. |
| DIETARY_SUPPLEMENT | Refined olive oil | Participants in the control group will receive 4 g refined olive oil daily |
Timeline
- Start date
- 2020-10-10
- Primary completion
- 2022-01-02
- Completion
- 2022-02-28
- First posted
- 2024-09-26
- Last updated
- 2025-08-13
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06614374. Inclusion in this directory is not an endorsement.